Full Paper
0.34 mmol) were added to a solution of octacycle 2 (50 mg,
0.11 mmol) and tetraphenylcyclopentadienone (65 mg, 0.17 mmol)
in a mixture of anhydrous THF (1.5 mL) and acetonitrile (1.5 mL),
and the mixture was heated at 60 °C for 17 h.
C34H37IO8Si (728.65): calcd. C 56.05, H 5.12, I 17.42; found C 55.97,
H 5.17, I 17.54.
Tetramethyl (1R*,3aS*,4R*,4aR*,4bS*,5R*,5aR*,9aR*,
10S*,10aS*,11R*,11aS*,12aR*,14S*,15S*)-3a,4,4a,4b,5,5a,9a,
10,10a,11,12,12a-Dodecahydro-4-iodo-15-(trimethylsilyl)-1H-
5,10,11a-(epiethane[1,1,2]triyl)-1,4,11-(epimethanetriyl)-
benzo[b]cyclopenta[h]fluorene-6,7,8,9-tetracarboxylate (11):
DMAD (0.1 mL, 0.79 mmol) and tris(dibenzylideneacetone)di-
palladium(0) (18 mg, 20 μmol) were added to a solution of octacy-
cle 2 (88 mg, 0.20 mmol) in anhydrous 1,4-dioxane (4.4 mL) and
the mixture was stirred and heated at 100 °C for 17 h. The reaction
mixture was cooled to room temperature and concentrated in
vacuo to give a brown solid (190 mg), which was submitted to
automated column chromatography [35–70 μm silica gel (4 g), hex-
ane/EtOAc mixtures]. On elution with hexane/AcOEt (3:1) to hex-
ane/AcOEt (7:3, 4 min), adduct 11 (117 mg, 81 % yield) was ob-
tained as a white solid. An analytical sample of 11 (93 mg) was
obtained as a white solid by crystallization of the above product
from CH2Cl2/pentane (1:3, 1.5 mL). Rf (silica gel, 10 cm, hexane/
EtOAc, 3:2) = 0.19; m.p. 117–118 °C (CH2Cl2/pentane). 1H NMR
(400 MHz, CDCl3): δ = 0.22 [s, 9 H, Si(CH3)3], 1.43 (overlapped s, 1
Reaction with Tetrabutylammonium Fluoride in the Presence of
Tetraphenylcyclopentadienone: Procedure 1: Tetraphenylcyclo-
pentadienone (65 mg, 0.17 mmol) was added to a cold (0 °C) sus-
pension of tetrabutylammonium fluoride (1
M in acetonitrile,
0.34 mL, 0.34 mmol). Then octacycle 2 (50 mg, 0.11 mmol) in anhy-
drous THF (50 μL) was added and the mixture was stirred at 0 °C
for 1 h.
Procedure 2: A suspension of tetrabutylammonium fluoride (1
M in
acetonitrile, 70 μL, 70 μmol) was added to a solution of octacycle
2 (10 mg, 22 μmol) and tetraphenylcyclopentadienone (17 mg,
44 μmol) in anhydrous 1,4-dioxane (0.5 mL), and the mixture was
heated at 100 °C for 19 h.
Reaction with CsF and AgF in the Presence of Anthracene: Anhy-
drous CsF (85 mg, 0.56 mmol) and AgF (43 mg, 0.34 mmol) were
added to a solution of octacycle 2 (50 mg, 0.11 mmol) and anthra-
cene (40 mg, 0.22 mmol) in a mixture of anhydrous 1,4-dioxane
(2.5 mL) and acetonitrile (1 mL), and the mixture was heated at
100 °C for 20 h.
2
3
H, 11-H), 1.46 [overlapped dd, J(H,H) = 10.2, J(H,H) = 2.8 Hz, 1 H,
13-Hb], 1.51–1.60 [complex signal, 3 H, 12-Ha, 12-Hb, 13-Ha], 1.82–
1.84 (m, 1 H, 12a-H), 1.94–1.96 (br. s, 2 H, 4a-H, 10-H), 2.00–2.02 (m,
Tetramethyl (1R*,3aS*,4R*,4aR*,4bR*,5R*,10S*,10aS*,
11S*,11aS*,12aR*,14S*,15S*)-3a,4,4a,4b,5,10,10a,11,12,12a-
Decahydro-4-iodo-15-(trimethylsilyl)-1H-5,10,11a-(epiethane-
[1,1,2]triyl)-1,4,11-(epimethanetriyl)benzo[b]cyclopenta[h]-
fluorene-6,7,8,9-tetracarboxylate (10): A 10 mL Schlenk tube
equipped with a reflux condenser and magnetic stirrer was charged
with a solution of octacycle 2 (50 mg, 0.11 mmol) in anhydrous
1,4-dioxane (2.5 mL) under Ar. Then DMAD (0.03 mL, 0.24 mmol),
tris(dibenzylideneacetone)dipalladium(0)·CHCl3 (6 mg, 6 μmol), an-
hydrous CsF (85 mg, 0.56 mmol), and AgF (43 mg, 0.34 mmol) were
successively added and the mixture was stirred and heated at
100 °C for 17 h. The reaction mixture was cooled to room tempera-
ture and concentrated in vacuo to give a brown solid (196 mg),
which was submitted to column chromatography [35–70 μm silica
gel (7 g), hexane/EtOAc mixtures] to give, on elution with hexane/
EtOAc (8:2), adduct 10 (28 mg, 34 % yield) as a white solid. An
analytical sample of 10 (20 mg) was obtained as a white solid by
crystallization of the above product from CH2Cl2/pentane (1:4,
1 mL). Rf (silica gel, 10 cm, hexane/EtOAc, 8:2) = 0.22; m.p. 117–
118 °C (CH2Cl2/pentane). 1H NMR (400 MHz, CDCl3): δ = 0.14 [s, 9
H, Si(CH3)3], 1.48 [dd, 2J(H,H) = 14.4, 3J(H,H) = 2.8 Hz, 1 H, 13-Hb],
1.60 [overlapped dd, 2J(H,H) = 14.8, 3J(H,H) = 3.2 Hz, 1 H, 13-Ha],
1.65 [overlapped d, 4J(H,H) = 0.8 Hz, 1 H, 11-H], 1.62–1.68 [complex
signal, 2 H, 12-Ha, 12-Hb], 1.90–1.93 (br. s, 1 H, 12a-H), 2.14–2.18 (br.
s, 2 H, 14-H, 4a-H), 2.24–2.28 (m, 2 H, 10a-H, 4b-H), 2.52–2.55 (br. s,
1 H, 1-H), 3.02–3.05 (br. s, 1 H, 3a-H), 3.26–3.28 (br. s, 1 H, 10-H),
3.48–3.50 (br. s, 1 H, 5-H), 3.86 (s, 3 H, OCH3), 3.88 (s, 3 H, OCH3),
3.90 (s, 3 H, OCH3), 3.93 (s, 3 H, OCH3), 5.99 [dd, 3J(H,H) = 6.0,
3J(H,H) = 3.2 Hz, 1 H, 3-H], 6.33 ppm [dd, 3J(H,H) = 6.0, 3J(H,H) =
3.2 Hz, 1 H, 2-H]. 13C NMR (100.6 MHz, CDCl3): δ = 3.9 [CH3, Si(CH3)3],
34.1 (CH2, C-13), 34.8 (CH2, C-12), 42.9 (C, C-11a), 43.2 (CH, C-10a),
45.9 (C, C-15), 48.6 (CH, C-4b), 50.5 (CH, C-10), 51.0 (CH, C-5), 52.0
(CH, C-14), 52.59 (CH, C-1), 52.61 (CH3), 52.8 (CH3), 52.91 (CH3), 52.94
(CH3, 4 COOCH3), 53.4 (CH, C-11), 54.6 (CH, C-12a), 63.2 (CH, C-4a),
63.4 (CH, C-3a), 68.8 (C, C-4), 126.6 (C) and 126.8 (C, C-7, C-8), 129.8
(C) and 130.4 (C, C-6, C-9), 139.5 (CH, C-3), 140.7 (CH, C-2), 150.8 (C,
C-9a), 151.3 (C, C-5a), 166.2 (C), 166.3 (C), 166.9 (C), 167.4 ppm (C,
3
1 H, 5-H), 2.22–2.26 (br. s, 1 H, 14-H), 2.36 [d, J(H,H) = 6.0 Hz, 1 H,
10a-H], 2.46 (overlapped br. s, 1 H, 1-H), 2.47 [overlapped d,
3J(H,H) = 6.0 Hz, 1 H, 4b-H], 2.90 [d, 3J(H,H) = 12.4 Hz, 1 H, 9a-H],
3
3
2.97 [d, J(H,H) = 2.4 Hz, 3aH], 3.08 [d, J(H,H) = 12.4 Hz, 1 H, 5a-H],
3.74 (s, 3 H, OCH3), 3.75 (s, 3 H, OCH3), 3.76 (s, 3 H, OCH3), 3.79 (s,
3 H, OCH3), 5.95 [dd, 3J(H,H) = 6.0, 3J(H,H) = 3.2 Hz, 1 H, 3-H],
6.29 ppm [dd, 3J(H,H) = 5.8, 3J(H,H) = 3.0 Hz, 1 H, 2-H]. 13C NMR
(100.6 MHz, CDCl3): δ = 4.0 [CH3, Si(CH3)3], 33.0 (CH2, C-13), 34.6
(CH2, C-12), 40.2 (CH, C-14), 43.60 (CH) and 43.64 (CH, C-5a, C-9a),
45.1 (C, C-15), 46.3 (CH, C-10a), 51.1 (CH, C-4b), 52.46 (CH, C-1),
52.47 (CH3), 52.59 (CH3), 52.62 (CH3), (4 COOCH3), 53.0 (CH, C-10),
53.2 (CH, C-5), 54.60 (CH) and 54.62 (CH, C-11, C-12a), 63.3 (CH, C-
3a), 64.4 (CH, C-4a), 69.5 (C, C-4), 130.6 (C, C-7), 131.6 (C, C-8), 133.1
(C, C-9), 134.7 (C, C-6), 139.2 (CH, C-3), 140.4 (CH, C-2), 166.5 (C) and
166.6 (C, 8-COOMe, 9-COOMe), 166.9 (C) and 167.0 ppm (C, 6-
COOMe, 7-COOMe); according to the gHMBC spectrum, C-11a
might be under the signals at δ = 43.60 and 43.64 ppm. IR (NaCl):
ν = 2949 (m), 2916 (m), 2840 (w), 1732 (s), 1644 (w), 1591 (w), 1434
˜
(s), 1342 (m), 1243 (s), 1117 (m), 993 (m), 849 (m), 836 (m), 727 cm–1
(m). HRMS: calcd. for C34H39IO8Si + NH4+ 748.1797; found 748.1801.
C34H39IO8Si·0.75CH2Cl2: calcd. C 52.54, H 5.14; found C 52.55, H 5.11.
Preparation of Compound 10 from 11: A solution of nonacycle 11
(51 mg, 0.07 mmol) in anhydrous 1,4-dioxane (1.5 mL) was placed
in a 10 mL flask equipped with a reflux condenser and magnetic
stirrer under Ar. Then anhydrous CsF (32 mg, 0.21 mmol) was added
and the mixture was stirred and heated at 100 °C for 16 h. The
reaction mixture was cooled to room temperature and concen-
trated in vacuo to give a white solid (87 mg), which was submitted
to column chromatography [35–70 μm silica gel (2 g), hexane/
EtOAc mixtures] to give, on elution with hexane/EtOAc (8:2), adduct
10 (45 mg, 89 % yield) as a white solid.
(1R*,3aS*,4R*,4aR*,4bS*,5R*,8S*,8aR*,9S*,9aS*,10aR*,11S*,
13S*)-4-Fluoro-13-(trimethylsilyl)-3a,4,4a,4b,5,8,8a,9,10,10a-
decahydro-1H-5,8,9a-(epiethane[1,1,2]triyl)-1,4,9-(epimeth-
anetriyl)cyclopenta[b]fluorene (12): A solution of octacycle 2
(63 mg, 0.14 mmol) in anhydrous dioxane (3 mL) was added to a
10 mL flask equipped with a reflux condenser and magnetic stirrer
under Ar. Then anhydrous AgF (54 mg, 0.43 mmol) was added and
4 COOCH3). IR (NaCl): ν = 2951 (m), 2918 (m), 1733 (s), 1444 (m),
˜
1361 (m), 1321 (m), 1249 (s), 1212 (s), 1166 (m), 1143 cm–1 (m).
+
HRMS: calcd. for C34H37IO8Si + NH4 746.1641; found 746.1635.
Eur. J. Org. Chem. 2017, 1594–1603
1600
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim